Michael Caligiuri, M.D.

 

Michael A. Caligiuri, M.D., the Deana and Steve Campbell Physician-in-Chief Distinguished Chair, is a world-renowned physician, scientist, builder, innovator, leader and visionary at City of Hope. He is dedicated to developing the next generation of leading-edge cancer therapies, rapidly delivering them to patients and ultimately curing the disease. 

For the past 20 years, Dr. Caligiuri has worked as a physician, scientist and leader in the cancer program at The Ohio State University. He spent the past decade as CEO of The James Cancer Hospital and Solove Research Institute and directed The Ohio State University Comprehensive Cancer Center for 14 years, recruiting over 300 cancer physicians and scientists. 

Dr. Caligiuri was elected to the National Academy of Medicine’s Class of 2018 for his breakthrough discoveries in NK leukemia and cutaneous T cell lymphoma. He is also the immediate past president of the American Association for Cancer Research, the world's largest cancer research organization with 40,000 members in 120 countries. In addition to serving as president of the AACR, he was also recently named a fellow of that organization.  

A leading researcher in the field of immunology, lymphoma and leukemia, more than 1,500 cancer patients have been treated on clinical trials developed or co-developed by Dr. Caligiuri. He also has trained over 120 undergraduate, graduate or postgraduate students in his laboratory who have received over 230 university, state, national or international awards.   

At City of Hope, Dr. Caligiuri's goals are “to speed up the delivery of our discoveries in the laboratory to our patients,” to use his inclusive leadership style to foster greater collaboration across the institution and with other institutions, and to “optimize the patient care system to ensure the highest quality and safest patient experience.”